Anesthetic Technique (Spinal vs. General Anesthesia) in Holmium Laser Enucleation of the Prostate: Retrospective Analysis of Procedural and Functional Outcomes among 1,159 Patients.


Journal

Urologia internationalis
ISSN: 1423-0399
Titre abrégé: Urol Int
Pays: Switzerland
ID NLM: 0417373

Informations de publication

Date de publication:
2023
Historique:
received: 02 12 2020
accepted: 29 03 2021
medline: 29 5 2023
pubmed: 18 8 2021
entrez: 17 8 2021
Statut: ppublish

Résumé

The aim of the study was to compare procedural efficacy, early and late functional outcomes in holmium laser enucleation of the prostate (HoLEP) under spinal anesthesia (SA) versus general anesthesia (GA). We retrospectively reviewed patients undergoing HoLEP at our institution between 2012 and 2017. Standard pre-, peri-, and postoperative characteristics were compared according to anesthetic technique. Multivariable logistic regression analyses (MVAs) were employed to study the impact of SA on procedural efficacy and postoperative complications. Our study cohort consisted of 1,159 patients, of whom 374 (32%) underwent HoLEP under SA. While a medical history of any anticoagulation/antiplatelet therapy except low-dose acetylsalicylic acid was significantly more common among patients undergoing GA (16% vs. 10%, p = 0.001), no other significant differences in preoperative characteristics were noted including age, body mass index, American Society of Anesthesiologists Classification (ASA), prostate size, or International Prostate Symptom Score (IPSS), and quality of life scores. Patients under SA exhibited shorter times of enucleation 42 min (interquartile range [IQR]:27-59 vs. 45 min [IQR: 31-68], p = 0.002), and combined time of enucleation/morcellation/coagulation (57 min [IQR: 38-85] vs. 64 min [IQR: 43-93], p = 0.002), as well as fewer complications (Clavien-Dindo ≥3) (12 [3.2%] vs. 55 [7%], p = 0.013). These associations were confirmed in MVA. Patients did not differ significantly with regard to early micturition including post-void residual volume and maximum flow-rate improvement. At a median follow-up of 33 months (IQR: 32-44), patients with SA had a lower IPSS score (median 3 [IQR: 1-6] vs. 4 [IQR: 2-7], p = 0.039). However, no significant differences were observed with respect to any urinary incontinence, urge symptoms, and postoperative pain. In this large retrospective series, HoLEP under SA was a safe and efficacious procedure with comparable early and long-term functional outcomes.

Identifiants

pubmed: 34404060
pii: 000517542
doi: 10.1159/000517542
doi:

Substances chimiques

Anesthetics 0
Holmium W1XX32SQN1

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

336-343

Informations de copyright

© 2021 S. Karger AG, Basel.

Auteurs

Hang Yu (H)

Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Philipp Gild (P)

Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Raisa S Pompe (RS)

Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Malte W Vetterlein (MW)

Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Tim A Ludwig (TA)

Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Armin Soave (A)

Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Mara Kölker (M)

Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Valentin Maurer (V)

Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Phillip Marks (P)

Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Andreas Becker (A)

Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Department of Urology, University Medical Center Frankfurt, Frankfurt, Germany.

Mark-Andree Punke (MA)

Department of Anesthesiology, Center of Anesthesiology and Intensive Care Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Margit Fisch (M)

Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Michael Rink (M)

Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Roland Dahlem (R)

Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Christian P Meyer (CP)

Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH